Abstract
Premature atherosclerosis is a major public health problem in the United States. Points at issue for the pediatrician are, for example: what is the appropriate age to identify various risk factors associated with early cardiovascular disease; what preventive measure should be implemented, and what really is the role of the pediatrician in such a task? Although it is not proven that reduction in plasma cholesterol will lower the incidence of coronary artery disease, most pediatricians agree that children that have inherited high cholesterol levels represent a group of sufficiently high risk to warrant identification and treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fredrickson, D.S. & Levy, R.I. Familial Hyperlipoproteinemia. In The Metabolic Basis of Inherited Disease, ed. Stanbury, J.B. Wyngaarden, J.B. & Fredrickson, D.S. 3rd Edn. Ch.26, New York: McGraw-Hill, p. 545–614. 1972.
Kwiterovich, P.O., Fredrickson, D.S. & Levy, R.I. Familial hypercholesterolemia (One form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood., J. Clin. Invest. 53:1237–1249, 1974.
Kwiterovich, P.O., Levy, R.I. & Fredrickson, D.S. Neonatal diagnosis of familial type II hyperlipoproteinemia. Lancet 1:118–122, 1973.
Glueck, C.J., Hickman, F., Schoenfeld, M., Steiner, P. & Pearce, W. Neonatal familial type II hyperlipoproteinemia: Cord blood cholesterol in 1880 births. Metabolism 20:597–608, 1971.
Brown, M.S. and Goldstein, J.L. Familial Hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3 Hydrozy 3 Methyl Glutaryl Coenzyme A Reductase activity. Proc. Nat. Acad. Sci. 71:788–792, 1974.
Glueck, C.J., Fallat, R. & Tsang, R. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. Pediatrics 52: 669–679, 1973.
West, R.J. & Lloyd, J.K. Use of cholestyramine in treatment of children with familial hypercholesterolemia. Arch. Dis. Childh. 48:320–374, 1973.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Farah, J.R., Kwiterovich, P.O., Neill, C.A. (1977). A Study of the Dose-Effect Relationship of Cholestyramine in Children with Familial Hypercholesterolemia. In: Manning, G.W., Haust, M.D. (eds) Atherosclerosis. Advances in Experimental Medicine and Biology, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4220-5_42
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4220-5_42
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4222-9
Online ISBN: 978-1-4613-4220-5
eBook Packages: Springer Book Archive